SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-094609
Filing Date
2024-08-29
Accepted
2024-08-29 08:52:45
Documents
15
Period of Report
2024-08-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2422951d1_8k.htm   iXBRL 8-K 23097
2 EXHIBIT 99.1 tm2422951d1_ex99-1.htm EX-99.1 11846
6 GRAPHIC tm2422951d1_ex99-1img001.jpg GRAPHIC 2744
  Complete submission text file 0001104659-24-094609.txt   215972

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nvct-20240829.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvct-20240829_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvct-20240829_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2422951d1_8k_htm.xml XML 3652
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41264 | Film No.: 241258952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)